Skip to main content

Meet the Analyst: Dr. Tara Speranza, Bell Potter Analyst Part 2

Grady Wulff
February 23, 2023

Continue on to learn about the remaining stocks, Microba Life Sciences (ASX:MAP) and Monash IVF (ASX:MVF), as well as what to expect from these companies in 2023.

In this video, Dr. Tara discusses:
– (0:34) Impacts of Ferring’s FDA approval on Microba
– (5:30) Drivers behind Microba’s increase in revenue
– (7:12) What 2023 looks like for Monash IVF
– (8:39) Monash IVF’s rating
– (11:45) Monash IVF’s impact from legal action

Note: This interview was filmed on 7 February 2023.

Weekly Wrap 23 August

Bell Direct
August 23, 2024

Morning Bell 22 August

Grady Wulff
August 22, 2024

Morning Bell 21 August

Bell Direct
August 21, 2024

Morning Bell 20 August

Bell Direct
August 20, 2024

Morning Bell 19 August

Bell Direct
August 19, 2024

Weekly Wrap 16 August

Bell Direct
August 16, 2024

Morning Bell 15 August

Bell Direct
August 15, 2024

Morning Bell 14 August

Grady Wulff
August 14, 2024

Morning Bell 13 August

Bell Direct
August 13, 2024

Morning Bell 12 August

Grady Wulff
August 12, 2024